标题
Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
作者
关键词
-
出版物
Cancers
Volume 12, Issue 5, Pages 1139
出版商
MDPI AG
发表日期
2020-05-05
DOI
10.3390/cancers12051139
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- BRCA1/P53: Two strengths in cancer chemoprevention
- (2020) Liliana Raimundo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- p53, cancer and the immune response
- (2020) Julianna Blagih et al. JOURNAL OF CELL SCIENCE
- Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
- (2020) Khaphetsi Joseph Mahasa et al. Scientific Reports
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma
- (2019) A-Rum Yoon et al. CANCER RESEARCH
- Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
- (2019) Julia Niemann et al. Nature Communications
- A tumor targeting oncolytic adenovirus can improve therapeutic outcomes in chemotherapy resistant metastatic human breast carcinoma
- (2019) Ali Sakhawat et al. Scientific Reports
- State‐of‐the‐art human adenovirus vectorology for therapeutic approaches
- (2019) Jian Gao et al. FEBS LETTERS
- Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
- (2018) Vincenzo Cerullo et al. CURRENT CANCER DRUG TARGETS
- The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
- (2018) Wei-Wei Zhang et al. HUMAN GENE THERAPY
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment
- (2018) M. Garofalo et al. JOURNAL OF CONTROLLED RELEASE
- Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors
- (2018) Peter Abbink et al. JOURNAL OF VIROLOGY
- Seamless assembly of recombinant adenoviral genomes from high-copy plasmids
- (2018) Jessica J. Miciak et al. PLoS One
- Novel Vector Construction Based on Alternative Adenovirus Types via Homologous Recombination
- (2018) Wenli Zhang et al. Human Gene Therapy Methods
- Designer Oncolytic Adenovirus: Coming of Age
- (2018) Alexander Baker et al. Cancers
- First-in-child trial of celyvir (autologous mesenchymal stem cells carrying the oncolytic virus ICOVIR-5) in patients with relapsed and refractory pediatric solid tumors.
- (2018) Manuel Ramirez et al. JOURNAL OF CLINICAL ONCOLOGY
- CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy
- (2018) Sadia Zafar et al. OncoImmunology
- Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies
- (2018) Mariangela Garofalo et al. Viruses-Basel
- Viral vector-based delivery of CRISPR/Cas9 and donor DNA for homology directed repair in an in vitro model for canine hemophilia B
- (2018) Jian Gao et al. Molecular Therapy-Nucleic Acids
- De-novo and acquired resistance to immune checkpoint targeting
- (2017) Nicholas L Syn et al. LANCET ONCOLOGY
- An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results
- (2017) Vignesh T. Packiam et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity
- (2017) Wenli Zhang et al. Cell Reports
- Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition
- (2017) Ali Sakhawat et al. Journal of Cancer
- Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
- (2017) Rocio Garcia-Carbonero et al. Journal for ImmunoTherapy of Cancer
- Combining Oncolytic Adenovirus with Radiation—A Paradigm for the Future of Radiosensitization
- (2017) Sean M. O’Cathail et al. Frontiers in Oncology
- The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model
- (2016) Xiaozhu Li et al. CLINICAL CANCER RESEARCH
- Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFN Combined with Chemotherapy
- (2016) D. H. Sterman et al. CLINICAL CANCER RESEARCH
- Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
- (2016) E Eriksson et al. GENE THERAPY
- Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer
- (2016) I. Liikanen et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer
- (2016) Di Yu et al. NEUROENDOCRINOLOGY
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
- (2016) Tuuli Ranki et al. Journal for ImmunoTherapy of Cancer
- Two distinct effector memory cell populations of WT1 (Wilms’ tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients
- (2015) Yoshiki Nakae et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study
- (2015) P. Johnson et al. CLINICAL CANCER RESEARCH
- Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA
- (2015) YANG GAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21
- (2015) XIAOMEI LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Human mastadenovirus type 70: a novel, multiple recombinant species D mastadenovirus isolated from diarrhoeal faeces of a haematopoietic stem cell transplantation recipient
- (2015) Elias Hage et al. JOURNAL OF GENERAL VIROLOGY
- CD8+CD103+Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
- (2015) Fayçal Djenidi et al. JOURNAL OF IMMUNOLOGY
- Human Adenovirus 52 Uses Sialic Acid-containing Glycoproteins and the Coxsackie and Adenovirus Receptor for Binding to Target Cells
- (2015) Annasara Lenman et al. PLoS Pathogens
- The Human Agonistic CD40 Antibody ADC-1013 Eradicates Bladder Tumors and Generates T-cell-Dependent Tumor Immunity
- (2014) S. M. Mangsbo et al. CLINICAL CANCER RESEARCH
- Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma
- (2014) Mikko Siurala et al. INTERNATIONAL JOURNAL OF CANCER
- Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
- (2014) Svend O. Freytag et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy
- (2013) S. Eisenstein et al. CANCER RESEARCH
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
- (2013) V.A. Jennings et al. INTERNATIONAL JOURNAL OF CANCER
- A Preclinical Evaluation of Neural Stem Cell–Based Cell Carrier for Targeted Antiglioma Oncolytic Virotherapy
- (2013) Atique U. Ahmed et al. JNCI-Journal of the National Cancer Institute
- Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement
- (2013) Zhili Xu et al. NATURE MEDICINE
- Molecular evolution of human adenoviruses
- (2013) Christopher M. Robinson et al. Scientific Reports
- The Timing of Neural Stem Cell-Based Virotherapy Is Critical for Optimal Therapeutic Efficacy When Applied With Radiation and Chemotherapy for the Treatment of Glioblastoma
- (2013) Alex L. Tobias et al. Stem Cells Translational Medicine
- Myeloid-derived suppressor cells as a Trojan horse
- (2013) Ping-Ying Pan et al. OncoImmunology
- Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) K. Oberg et al. ANNALS OF ONCOLOGY
- Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation
- (2012) M. Muthana et al. CANCER RESEARCH
- Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells
- (2012) Robert A. Adair et al. INTERNATIONAL JOURNAL OF CANCER
- Human Telomerase Reverse Transcriptase (hTERT) Is a Novel Target of the Wnt/β-Catenin Pathway in Human Cancer
- (2012) Yong Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes following Vaccination of Rhesus Monkeys
- (2012) H. Li et al. JOURNAL OF VIROLOGY
- Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer
- (2012) Otto Hemminki et al. MOLECULAR THERAPY
- Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects
- (2012) Padma Sampath et al. MOLECULAR THERAPY
- Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting
- (2012) Jun Fu et al. NATURE BIOTECHNOLOGY
- Adenovirus receptors: implications for targeting of viral vectors
- (2012) Niklas Arnberg TRENDS IN PHARMACOLOGICAL SCIENCES
- Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
- (2011) Jens Rüter et al. CANCER BIOLOGY & THERAPY
- Mining the adenovirus virome for oncolytics against multiple solid tumor types
- (2011) C Y Chen et al. CANCER GENE THERAPY
- Species D Adenoviruses as Oncolytics against B-cell Cancers
- (2011) C. Y. Chen et al. CLINICAL CANCER RESEARCH
- Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
- (2011) D. Yu et al. JOURNAL OF VIROLOGY
- A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant Glioma
- (2011) Atique U. Ahmed et al. MOLECULAR PHARMACEUTICS
- Neural Stem Cell-based Cell Carriers Enhance Therapeutic Efficacy of an Oncolytic Adenovirus in an Orthotopic Mouse Model of Human Glioblastoma
- (2011) Atique U Ahmed et al. MOLECULAR THERAPY
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- A Novel Oncolytic Adenovirus Expressing Escherichia coli Cytosine Deaminase Exhibits Potent Antitumor Effect on Human Solid Tumors
- (2010) Jufeng Zhang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Oncolytic adenovirus based on serotype 3
- (2010) O Hemminki et al. CANCER GENE THERAPY
- Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients
- (2010) Vincenzo Cerullo et al. CANCER RESEARCH
- Serotype-Specific Inactivation of the Cellular DNA Damage Response during Adenovirus Infection
- (2010) N. A. Forrester et al. JOURNAL OF VIROLOGY
- Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses
- (2010) Juan J Rojas et al. MOLECULAR THERAPY
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
- (2010) Anniina Koski et al. MOLECULAR THERAPY
- Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
- (2010) Hongjie Wang et al. NATURE MEDICINE
- The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis
- (2010) Emma C Nilsson et al. NATURE MEDICINE
- Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability
- (2010) Justyna Leja et al. PLoS One
- Looking Inside Adenovirus
- (2010) S. C. Harrison SCIENCE
- Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade
- (2010) Jeffrey Weber SEMINARS IN ONCOLOGY
- Targeting p53 for enhanced radio- and chemo-sensitivity
- (2009) Chao Lu et al. APOPTOSIS
- Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
- (2009) R. C. Carlisle et al. BLOOD
- Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo
- (2009) I V Ulasov et al. BRITISH JOURNAL OF CANCER
- Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
- (2009) E J Ilett et al. GENE THERAPY
- Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma
- (2009) Ranjana Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Temporal Regulation of the Mre11-Rad50-Nbs1 Complex during Adenovirus Infection
- (2009) K. A. Karen et al. JOURNAL OF VIROLOGY
- Enzymatic assembly of DNA molecules up to several hundred kilobases
- (2009) Daniel G Gibson et al. NATURE METHODS
- The Janus faces of CD40 in cancer
- (2009) Angelica S.I. Loskog et al. SEMINARS IN IMMUNOLOGY
- Low-Dose Radiation Enhances Survivin-Mediated Virotherapy against Malignant Glioma Stem Cells
- (2008) S. Nandi et al. CANCER RESEARCH
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
- Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery
- (2008) S H Thorne et al. GENE THERAPY
- The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer
- (2008) David H. Lynch IMMUNOLOGICAL REVIEWS
- Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
- (2008) Irene Kuhn et al. PLoS One
- Evaluation of Twenty-One Human Adenovirus Types and One Infectivity-Enhanced Adenovirus for the Treatment of Malignant Melanoma
- (2007) Dennis Hoffmann et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search